1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic and molecular correlates to neoadjuvant chemotherapy (NACT) pathologic response in breast angiosarcoma (AS)
    Meeting Abstract

    Chang, H. Y.; Dermawan, J.; Antonescu, C.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Defining novel genomic risk stratification models underlying leiomyosarcoma subtypes
    Meeting Abstract

    Dermawan, J.; Chiang, S.; Antonescu, C.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Botryoides-type embryonal rhabdomyosarcoma (ERMS): A clinicopathologic and molecular appraisal of 25 cases across anatomic locations, with emphasis on disparities with its conventional-type counterpart
    Meeting Abstract

    Sharma, A.; Dermawan, J.; Chiang, S.; Wexler, L.; Antonescu, C.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Epithelioid vascular neoplasms with NFATC1/C2 gene alterations: Expanding the clinicopathologic and molecular characteristics of a distinct entity
    Meeting Abstract

    Dashti, N.; Perret, R.; Balzer, B.; Michal, M.; Antonescu, C.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma
    Meeting Abstract

    Saoud, C.; Dermawan, J.; Sharma, A.; Wexler, L.; Antonescu, C.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • A comprehensive clinicopathologic and molecular reappraisal of GLI1-altered mesenchymal neoplasms with outcome meta-analysis showing poor survival in GLI1 amplified vs fusion tumors
    Meeting Abstract

    Saoud, C.; Agaram, N.; Antonescu, C.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • N/KRAS-mutant AML LSCS originate from committed myelomonocytic progenitors and drive clinical resistance to venetoclax
    Meeting Abstract

    Sango, J.; Carcamo, S.; Sirenko, M.; Maiti, A.; Mansour, H.; Ulukaya, G.; Tomalin, L.; Olivier, E.; Olszewska, M.; Demircioglu, D.; more...
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • Production of alarmins S100a8/A9 by DNMT3A-mutant hematopoietic cells causes mesenchymal stromal cell senescence and seeds a pro-inflammatory environment in clonal hematopoiesis
    Meeting Abstract

    Mistry, J.; Young, K.; Maestre, I. F.; Levine, R.; Trowbridge, J.
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • Radiotherapy and theranostics: A Lancet Oncology Commission
    Review

    Abdel-Wahab, M.; Giammarile, F.; Carrara, M.; Paez, D.; Hricak, H.; Ayati, N.; Li, J. J.; Mueller, M.; Aggarwal, A.; Al-Ibraheem, A.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Characteristics and outcomes of patients with SMARCA4-deficient undifferentiated thoracic tumors
    Meeting Abstract

    Cooper, A.; Ricciuti, B.; Gagne, A.; Sholl, L.; Di Federico, A.; Awad, M.; Aldea, M.; Ghigna, M. R.; Grecea, M.; Chaft, J.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save